Table 5.
Results of Multiple Linear and Logistic Regressions Examining the Interaction Between Frailty and HIV/Methamphetamine Group on Global Neurocognition and Everyday Functioning
| Outcome: global T-score | |||
|---|---|---|---|
| Predictor variables | Estimate | 95% CI | p |
| Frailty index score | −17.60 | −33.62 to −1.58 | .018 |
| HIV−/MA− (vs. HIV+/MA+) | 1.26 | −1.75 to 4.27 | .410 |
| HIV+/MA− (vs. HIV+/MA+) | −1.14 | −4.12 to 1.83 | .448 |
| Frailty index score × HIV−/MA− | 7.05 | −16.84 to 30.93 | .561 |
| Frailty index score × HIV+/MA− | 13.25 | −9.59 to 36.09 | .254 |
| Outcome: IADL dependence | |||
|---|---|---|---|
| Predictor variables | Logit | 95% CI | p |
| Frailty index score (per 0.10 U change) | 0.45 | 0.07 to 0.83 | .021 |
| HIV−/MA− (vs. HIV+/MA+) | −0.84 | −1.58 to −0.21 | .014 |
| HIV+/MA− (vs. HIV+/MA+) | 0.25 | −0.33 to 0.83 | .398 |
| Frailty index score × HIV−/MA− | −0.42 | −10.22 to 1.51 | .155 |
| Frailty index score × HIV+/MA− | 0.10 | −0.36 to 0.58 | .680 |
Bold values indicate p-values significant at <0.05.